FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36506311000001102: Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Jan 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111632101000001110 Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111632201000001115 Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Is a Mebeverine 135mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has AMP Mebeverine 135mg tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has basis of strength substance Mebeverine hydrochloride true Inferred relationship Existential restriction modifier 1
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has presentation strength numerator value 135 false Inferred relationship Existential restriction modifier 1
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has precise active ingredient Mebeverine hydrochloride true Inferred relationship Existential restriction modifier 1
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has specific active ingredient Mebeverine hydrochloride true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Aspire Pharma Ltd) 100 tablet 5 x 20 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start